Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan de Boer

Showing results (251-260 of 327) with videos related to

Pageof 33
Sort By:
Journal of the American College of Cardiology|April 6, 2005
Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarctionJorik R Timmer, Jan Paul Ottervanger, Menko-Jan de Boer, et al.
American Heart Journal|October 8, 2005
Preprocedural Thrombolysis in Myocardial Infarction (TIMI) flow significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute anterior myocardial infarction treated by primary angioplastyGiuseppe De Luca, Nicolette Ernst, Arnoud W J van 't Hof, et al.
European Heart Journal|August 12, 2003
A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b/3a upstream therapy and acute coronary syndromesArnoud W J van 't Hof, Suzanna T de Vries, Jan-Henk E Dambrink, et al.
Thrombosis and Haemostasis|August 12, 2011
Suboptimal anticoagulation with pre-hospital heparin in ST-elevation myocardial infarctionRenicus S Hermanides, Jan Paul Ottervanger, Jan-Henk E Dambrink, et al.
American Heart Journal|December 13, 2005
Circadian variation in myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplastyGiuseppe De Luca, Harry Suryapranata, Jan Paul Ottervanger, et al.
American Heart Journal|December 13, 2005
Prognostic significance of residual cumulative ST-segment deviation after mechanical reperfusion in patients with ST-segment elevation myocardial infarctionGiuseppe De Luca, Arthur C Maas, Harry Suryapranata, et al.
American Heart Journal|September 20, 2005
Unsuccessful reperfusion in patients with ST-segment elevation myocardial infarction treated by primary angioplastyGiuseppe De Luca, Arnoud W J van 't Hof, Jan Paul Ottervanger, et al.
The American Journal of Cardiology|July 7, 2009
Comparison of rapamycin- and paclitaxel-eluting stents in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarctionYahya B Juwana, Harry Suryapranata, Jan Paul Ottervanger, et al.
American Heart Journal|June 20, 2006
Predictors and clinical implications of early reinfarction after primary angioplasty for ST-segment elevation myocardial infarctionGiuseppe De Luca, Nicolette Ernst, Arnoud W J van 't Hof, et al.
Frontiers in Bioengineering and Biotechnology|July 14, 2018
Designed Surface Topographies Control ICAM-1 Expression in Tonsil-Derived Human Stromal CellsAliaksei S Vasilevich, Frédéric Mourcin, Anouk Mentink, et al.
Pageof 33

Showing results (251-260 of 327) with videos related to

Sort By:
Pageof 33
Journal of the American College of Cardiology|April 6, 2005
Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarctionJorik R Timmer, Jan Paul Ottervanger, Menko-Jan de Boer, et al.
American Heart Journal|October 8, 2005
Preprocedural Thrombolysis in Myocardial Infarction (TIMI) flow significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute anterior myocardial infarction treated by primary angioplastyGiuseppe De Luca, Nicolette Ernst, Arnoud W J van 't Hof, et al.
European Heart Journal|August 12, 2003
A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b/3a upstream therapy and acute coronary syndromesArnoud W J van 't Hof, Suzanna T de Vries, Jan-Henk E Dambrink, et al.
Thrombosis and Haemostasis|August 12, 2011
Suboptimal anticoagulation with pre-hospital heparin in ST-elevation myocardial infarctionRenicus S Hermanides, Jan Paul Ottervanger, Jan-Henk E Dambrink, et al.
American Heart Journal|December 13, 2005
Circadian variation in myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplastyGiuseppe De Luca, Harry Suryapranata, Jan Paul Ottervanger, et al.
American Heart Journal|December 13, 2005
Prognostic significance of residual cumulative ST-segment deviation after mechanical reperfusion in patients with ST-segment elevation myocardial infarctionGiuseppe De Luca, Arthur C Maas, Harry Suryapranata, et al.
American Heart Journal|September 20, 2005
Unsuccessful reperfusion in patients with ST-segment elevation myocardial infarction treated by primary angioplastyGiuseppe De Luca, Arnoud W J van 't Hof, Jan Paul Ottervanger, et al.
The American Journal of Cardiology|July 7, 2009
Comparison of rapamycin- and paclitaxel-eluting stents in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarctionYahya B Juwana, Harry Suryapranata, Jan Paul Ottervanger, et al.
American Heart Journal|June 20, 2006
Predictors and clinical implications of early reinfarction after primary angioplasty for ST-segment elevation myocardial infarctionGiuseppe De Luca, Nicolette Ernst, Arnoud W J van 't Hof, et al.
Frontiers in Bioengineering and Biotechnology|July 14, 2018
Designed Surface Topographies Control ICAM-1 Expression in Tonsil-Derived Human Stromal CellsAliaksei S Vasilevich, Frédéric Mourcin, Anouk Mentink, et al.
Pageof 33